Q1 2023 13F Holders as of 3/31/2023
-
Type / Class
-
Equity / Common Stock, $0.01 par value per share
-
Shares outstanding
-
49.7M
-
Number of holders
-
601
-
Total 13F shares, excl. options
-
50.4M
-
Shares change
-
+1.35M
-
Total reported value, excl. options
-
$10.2B
-
Value change
-
+$259M
-
Put/Call ratio
-
1.16
-
Number of buys
-
300
-
Number of sells
-
-266
-
Price
-
$201.82
Significant Holders of CHARLES RIVER LABORATORIES INTERNATIONAL, INC. - Common Stock, $0.01 par value per share (CRL) as of Q1 2023
693 filings reported holding CRL - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. - Common Stock, $0.01 par value per share as of Q1 2023.
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. - Common Stock, $0.01 par value per share (CRL) has 601 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 50.4M shares
.
Largest 10 shareholders include VANGUARD GROUP INC (6.02M shares), BlackRock Inc. (4.79M shares), PRICE T ROWE ASSOCIATES INC /MD/ (2.51M shares), STATE STREET CORP (2.05M shares), KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC (1.63M shares), Clearbridge Investments, LLC (1.41M shares), Allspring Global Investments Holdings, LLC (1.16M shares), GEODE CAPITAL MANAGEMENT, LLC (1.06M shares), MARSHALL WACE, LLP (955K shares), and Jackson Square Partners, LLC (904K shares).
This table shows the top 601 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.